Rabies (Q56751593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

Rabies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Reeta Subramaniam Mani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Susan Nadin-Davis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Anthony R Fooks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Ashley C Banyard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Thiravat Hemachudha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Stefan Finke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Thomas Müller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Evelyne Picard-Meyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Henry Wilde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Conrad Freuling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

English

0 references

publication date

30 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Disease Primers

5 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

17091

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

Taxonomy of the order Mononegavirales: update 2016

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Current status of rabies and prospects for elimination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The dilemma of managing human rabies encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Eliminating canine rabies, the principal source of human infection: what will it take?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Elimination of Dog-Mediated Human Rabies Deaths by 2030: Needs Assessment and Alternatives for Progress Based on Dog Vaccination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Aiming for elimination of dog-mediated human rabies cases by 2030

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies in India: an ABC approach to combating the disease in street dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

2016: the beginning of the end of rabies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Complete genome and molecular epidemiological data infer the maintenance of rabies among kudu (Tragelaphus strepsiceros) in Namibia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Elucidating the phylodynamics of endemic rabies virus in eastern Africa using whole-genome sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Complex epidemiology of a zoonotic disease in a culturally diverse region: phylogeography of rabies virus in the Middle East

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The origin and phylogeography of dog rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Antigenic and genetic characterization of rabies viruses isolated from domestic and wild animals of Brazil identifies the hoary fox as a rabies reservoir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Molecular characterization of cryptically circulating rabies virus from ferret badgers, Taiwan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Development of a multivalent paediatric human vaccine for rabies virus in combination with Measles-Mumps-Rubella (MMR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Estimating the global burden of endemic canine rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Eliminating the scourge of dog-transmitted rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies encephalitis in malaria-endemic area, Malawi, Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The feasibility of canine rabies elimination in Africa: dispelling doubts with data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Transmission of rabies virus from an organ donor to four transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Virus Transmission in Solid Organ Transplantation, China, 2015-2016.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Airborne transmission of lyssaviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

An outbreak of non-bite transmitted rabies in a laboratory animal colony

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Effects of aerosolized rabies virus exposure on bats and mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Double-labeled rabies virus: live tracking of enveloped virus transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Virus Hijacks and accelerates the p75NTR retrograde axonal transport machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Inhibition of the transport of rabies virus in the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Internalizes into Primary Peripheral Neurons via Clathrin Coated Pits and Requires Fusion at the Cell Body

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Human rabies: neuropathogenesis, diagnosis, and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Is the acetylcholine receptor a rabies virus receptor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

31 March 2020

Rabies virus receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

In vivo differential susceptibility of sensory neurons to rabies virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Anterograde glycoprotein-dependent transport of newly generated rabies virus in dorsal root ganglion neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Mapping sensory circuits by anterograde transsynaptic transfer of recombinant rabies virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies virus clearance from the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

CXCL10 and blood-brain barrier modulation in rabies virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Role of the blood-brain barrier in rabies virus infection and protection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Therapeutic Immune Clearance of Rabies Virus from the CNS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The immune response to rabies virus infection and vaccination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Evasive strategies in rabies virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Pathology of the spinal cord of C57BL/6J mice infected with rabies virus (CVS-11 strain).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Lesions of the central nervous system induced by intracerebral inoculation of BALB/c mice with rabies virus (CVS-11).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Intracellular Spread of Rabies Virus Is Reduced in the Paralytic Form of Canine Rabies Compared to the Furious Form

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Reduced viral burden in paralytic compared to furious canine rabies is associated with prominent inflammation at the brainstem level.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Virus Infection Induces the Formation of Stress Granules Closely Connected to the Viral Factories.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Antiviral innate immunity and stress granule responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Strategies to interfere with PDZ-mediated interactions in neurons: What we can learn from the rabies virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Neuronal apoptosis does not play an important role in human rabies encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Wild-type rabies virus induces autophagy in human and mouse neuroblastoma cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Regional distribution of rabies viral antigen in central nervous system of human encephalitic and paralytic rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Difference in neuropathogenetic mechanisms in human furious and paralytic rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Apoptotic cell death in experimental rabies in suckling mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies and other lyssavirus diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Pathophysiology of human paralytic rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Immunovirological correlates in human rabies treated with therapeutic coma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Excretion of rabies virus in the saliva of dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

A reliable diagnosis of human rabies based on analysis of skin biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Development of real-time reverse transcriptase polymerase chain reaction methods for human rabies diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies - the need for a 'one medicine' approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Failure of postexposure treatment of rabies in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Ante- and post-mortem diagnosis of rabies using nucleic acid-amplification tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Human rabies in India: an audit from a rabies diagnostic laboratory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Human Rabies: a 2016 Update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Comparison of biotinylated monoclonal and polyclonal antibodies in an evaluation of a direct rapid immunohistochemical test for the routine diagnosis of rabies in southern Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

A Pan-Lyssavirus Taqman Real-Time RT-PCR Assay for the Detection of Highly Variable Rabies virus and Other Lyssaviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Risk factors associated with travel to rabies endemic countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Use of rabies vaccines after reconstitution and storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies cell culture vaccines reconstituted and stored at 4 degrees C for 1 year prior to use protect mice against rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Potency, sterility and immunogenicity of rabies tissue culture vaccine after reconstitution and refrigerated storage for 1 week

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Inferior rabies vaccine quality and low immunization coverage in dogs ( Canis familiaris) in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Pre-exposure rabies prophylaxis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies vaccines: WHO position paper—Recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The incurable wound revisited: progress in human rabies prevention?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

INFECTIOUS DISEASE. Scandal clouds China's global vaccine ambitions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Passive immunity in the prevention of rabies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

A 4‐Site, Single‐Visit Intradermal Postexposure Prophylaxis Regimen for Previously Vaccinated Patients: Experiences with >5000 Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Post-exposure rabies prophylaxis in patients with AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Postexposure rabies prophylaxis completed in 1 week: preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Worldwide rabies deaths prevention--A focus on the current inadequacies in postexposure prophylaxis of animal bite victims

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Intradermal pre-exposure rabies vaccine elicits long lasting immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Six fatal cases of classical rabies virus without biting incidents, Iran 1990-2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

A Systematic Review of Human Bat Rabies Virus Variant Cases: Evaluating Unprotected Physical Contact with Claws and Teeth in Support of Accurate Risk Assessments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Caring for patients with rabies in developing countries - the neglected importance of palliative care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Human Rabies Survivors in India: An Emerging Paradox?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Why does the prognosis remain so poor in human rabies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Current and future approaches to the therapy of human rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Survival from rabies encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Knowledge, attitudes and practices (KAP) about rabies prevention and control: a community survey in Tanzania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Survival after treatment of rabies with induction of coma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Laboratory diagnostics in dog-mediated rabies: an overview of performance and a proposed strategy for various settings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The SARE tool for rabies control: Current experience in Ethiopia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The Road to Dog Rabies Control and Elimination-What Keeps Us from Moving Faster?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Immunization coverage required to prevent outbreaks of dog rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Transmission dynamics and prospects for the elimination of canine rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Vaccination Targets for Stray Dog Populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Implementation of an intersectoral program to eliminate human and canine rabies: the Bohol Rabies Prevention and Elimination Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Inhibition of rabies virus replication by multiple artificial microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Transvascular delivery of small interfering RNA to the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Management and modeling approaches for controlling raccoon rabies: The road to elimination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies: 100 per cent fatal, 100 per cent preventable

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Potential economic benefits of eliminating canine rabies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies virus matrix protein regulates the balance of virus transcription and replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Membrane and inclusion body targeting of lyssavirus matrix proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Structure of the glycoprotein gene in rabies virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The cell biology of rabies virus: using stealth to reach the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies Virus Nucleoprotein Functions To Evade Activation of the RIG-I-Mediated Antiviral Response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

RelAp43, a member of the NF-κB family involved in innate immune response against Lyssavirus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The matrix protein of rabies virus binds to RelAp43 to modulate NF-κB-dependent gene expression related to innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

5'-Triphosphate RNA is the ligand for RIG-I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Taxonomy of the order Mononegavirales: update 2017.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Recovery from rabies, a universally fatal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Pituitary cachexia after rabies encephalitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Unique clinical and imaging findings in a first ever documented PCR positive rabies survival patient: A case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Partial recovery from rabies in a six-year-old girl

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Partial recovery from rabies in a nine-year-old boy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Recovery from Rabies in Man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Recovery from rabies. A case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

inferred from DOI database lookup

7 January 2021

based on heuristic

Autophagy is highly targeted among host comparative proteomes during infection with different virulent RABV strains

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

inferred from DOI database lookup

7 January 2021

based on heuristic

Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2017.91

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRDP.2017.91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29188797%20AND%20SRC:MED&resulttype=core&format=json